Page 136 - Influenza Report

136 Preparativi per una pandemia

12. CP/BSB 2003. Clinical Pharmacology/Biopharmaceutics Summary Background 2003.
http://www.fda.gov/cder/foi/esum/2004/21246slr010,21087slr016_Tamiflu_Pharm_Biop
harm _BPCA.pdf
13. de Jong MD, Thanh TT, Khank TH, et al. Oseltamivir resistance during treatment of
influenza A (H5N1) infection. N Engl J Med 2005; 353: 2667-72. Full text at
http://content.nejm.org/cgi/content/full/353/25/2667

14. Enserink M. Meeting seeks global consensus, highlights global disparities. Science
2005; 310: 1103.
15. Fal Falsey AR, Criddle MM, Kolassa JE, McCann RM, Brower CA, Hall WJ. Evaluation
of a handwashing intervention to reduce respiratory illness rates in senior day-care
centers. Infect Control Hosp Epidemiol 1999; 20: 200-2. Abstract:
http://amedeo.com/lit.php?id=10100548
16. FAO 2005. FAO Avian influenza disease emergency. Update on the avian influenza
situation (as of 12/11/2005) - Issue no. 36. Available at:
http://www.fao.org/ag/againfo/subjects/documents/ai/AVIbull036.pdf

17. FAO, OIE, WHO 2005. A Food and Agriculture Organisation (FAO), World Organisation
for Animal Health (OIE) in collaboration with World Health Organisation (WHO) Global
Strategy for the Progressive Control of Highly Pathogenic Avian Influenza (HPAI).
November 2005. Available at:
http://www.fao.org/ag/againfo/resources/documents/empres/AI_globalstrategy.pdf
18. Ferguson NM, Cummings DA, Cauchemez S, et al. Strategies for containing an
emerging influenza pandemic in Southeast Asia. Nature 2005; 437: 209-14. Abstract:
http://amedeo.com/lit.php?id=16079797

19. Ferguson NM, Fraser C, Donnelly CA, Ghani AC, Anderson RM. Public health risk from
the avian H5N1 influenza epidemic. Science 2004; 304: 968-69.
20. Flahault A, Dias-Ferrao V, Chaberty P, Esteves K, Valleron AJ, Lavanchy D. Flu Net as
a tool for global monitoring of influenza on the Web. JAMA 1998; 280: 1330-2. Full text
at http://jama.ama-assn.org/cgi/content/full/280/15/1330

21. Fleming D. Influenza pandemics and avian flu. BMJ 2005;331:1066-9.
22. Fraser C, Riley S, Anderson RM, Ferguson NM. Factors that make an infectious
disease outbreak controllable. PNAS 2004; 101: 6146-51. Full text at
http://www.pnas.org/cgi/content/abstract/101/16/6146
23. Groeneveld K, van der Noordaa J. Use of antiviral agents and other measures in an
influenza pandemic. The Neth J Med 2005; 63: 339-43. Full text at
http://www.zuidencomm.nl/njm/getpdf.php?id=437

24. Gubareva LV, Kaiser L, Matrosovich MN, Soo-Hoo Y, Hayden FG. Selection of
influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J
Infect Dis 2001; 183: 523-31. Full text at
http://www.journals.uchicago.edu/JID/journal/issues/v183n4/000943/000943.html
25. Hayden F, Croisier A. Transmission of Avian Influenza Viruses to and between
Humans. The J Infec Dis 2005; 192: 1311-4.
26. Hayden FG. Antivirals for pandemic influenza. J Infect Dis 1997; 176: Suppl 1: Abstract:
http://amedeo.com/lit.php?id=9240696